US Centers for Disease Control and Prevention on diabetes

Local News

The US Centers for Disease Control and Prevention says diabetes is the 7th leading cause of death in the United States and affects nearly 10 percent of the US population.  

The federal government supports important Diabetes Research at the National Institutes of Health to the tune of $150 million a year.  

That funding will dry up unless Congress acts soon.  

As NewsChannel 34’s Morgan Wright shows us, Corning Congressman Tom Reed is backing a bill that would insure the research for a diabetes cure continues. 

For New York Congressman Tom Reed, finding a cure for diabetes is personal…diagnosed age 4, and now is 18. Reed says his son – has Type 1 diabetes…

My wife, god bless her, up at 2 o’clock 3 o’clock poking his fingers in the morning to make sure his blood sugars were not life-threatening. 
Reed is the co-chair of the Congressional Diabetes Caucus — he’s backing – a bill- which would preserve critical funding for Diabetes research at the National Institutes of Health. 
Millions of Americans are affected by this, federal funding for the research program is set to expire in September.

Meghan Riley with the American Diabetes Association says the money supports important research…
They’re looking for enhanced treatments, they’re looking for a cure.

The bill would actually increase federal funding to the program for the first time since 2004.

Riley says it would be money well spent.

Diabetes is our most costly chronic disease at 372 billion dollars a year, so if you can cure diabetes or you can make it a chronic condition where the health impacts are limited you reduce the overall healthcare costs for America so it’s a win-win for all of America.

Reed says he’s optimistic Congress will come together to pass the bill…before the money runs out.


Download the app for Android or iPhone

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss - Vertical

More Don't Miss